Coeurative, Inc. is a privately owned pharmaceutical development company incorporated in Delaware and operating in Virginia. The company was formed to create and develop curative strategies for the management of cardiovascular and cardiopulmonary diseases associated with cellular hypoxia. The patented compounds developed by Coeurative generate nitric oxide in cells that line the inside of blood vessels, known as endothelial cells. Nitric oxide acts as a vasodilator and a modulator of inflammation.